Amgen to invest $600 million in new research and development facility in California | AI News Digest
Amgen is set to invest over $600 million in a new research and development facility at its Thousand Oaks headquarters in California. This initiative is part of a broader trend of U.S. investments by the pharmaceutical industry amid potential tariffs on imported drugs. The facility, expected to begin construction in the third quarter, aims to create hundreds of jobs and enhance collaboration among researchers and scientists. CEO Bob Bradway emphasized the importance of this investment in advancing American science and innovation. The facility will feature advanced automation and digital capabilities to support the development of next-generation drugs for serious diseases.
